Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Zanzalintinib in Men With Aggressive Variant Prostate Cancer [Phase 2]
A Phase 2 clinical trial of Zanzalintinib for aggressive variant prostate cancer is not yet recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-10-21Clinical Trial Update: PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer [Phase 2]
A Phase 2 trial evaluating PSMA-targeted 18F-DCFPyL PET/MRI for detecting prostate cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial [Phase 2]
Phase 2 trial evaluating relugolix and enzalutamide with radiation therapy for very high risk prostate cancer (OPTIMAL trial) is recruiting.
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects [Phase 2]
This is a Phase 2 clinical trial update evaluating Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone plus Olaparib in patients wit…
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients [NA]
A Memorial Sloan Kettering Cancer Center study to develop educational materials about genetic testing for a diverse group of cancer patients…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer [Phase 2]
Phase 2 clinical trial update on salvage oligometastasectomy and radiation therapy for recurrent prostate cancer with oligometastatic diseas…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Gadopiclenol in Contrast Enhanced MRI of the Prostate [Phase 4]
Phase 4 clinical trial evaluating gadopiclenol as a contrast agent for MRI in prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Exercise in Prostate Cancer [NA]
A Johns Hopkins-led clinical trial is currently recruiting to evaluate the effects of exercise on patients with prostate cancer, including m…
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression [EARLY_Phase 1]
This early Phase 1 trial update reports results from an investigation of an androgen receptor partial agonist in prostate cancer patients on…
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC [Phase 1]
Phase 1 study evaluating Acapatamab in metastatic castration-resistant prostate cancer reports safety, tolerability, pharmacokinetics, and p…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide [Phase 2]
Phase 2 ARAMON study comparing darolutamide with enzalutamide to evaluate the effect on testosterone levels in men with biochemically recurr…
-
CLINICAL_TRIALS withdrawal · 2025-10-15Clinical Trial Update: A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence [NA]
The University of Rochester's study evaluating focal salvage high-dose-rate brachytherapy for prostate gland recurrence has been withdrawn.
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
This ClinicalTrials.gov update describes the ARCTIC study from Duke University, a prospective set of trials investigating liquid biomarkers …
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy [NA]
A completed clinical trial evaluated whether Vitamin B6 (pyridoxine) can reduce hot flashes in men with prostate cancer undergoing antiandro…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). [Phase 2]
Phase 2 ARROW trial comparing I-131-1095 radioligand plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies [Phase 1, Phase 2]
This Phase 1/2 trial assesses a combination of Avelumab, Utomilumab, and anti-OX40 PF-04518600 with radiation therapy in patients with advan…
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer
This clinical trial investigates tear and blood biomarkers to discover signatures associated with aggressive prostate cancer.
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues [Phase 1, Phase 2]
Clinical trial update for an acupuncture study in prostate cancer survivors with urinary issues; the trial is ongoing in Phase 1/Phase 2 and…
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound
PRISM is a recruiting study evaluating PSMA PET/MRI imaging after high-intensity focused ultrasound to detect recurrence of prostate cancer.
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study
The ENGAGEMENT study from Thomas Jefferson University aims to enhance genetic awareness and genetic evaluation for men with prostate cancer;…
-
CLINICAL_TRIALS other · 2025-10-10Clinical Trial Update: Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer [Phase 2, Phase 3]
Phase 2/3 clinical trial investigating methylphenidate and exercise to reduce cancer-related fatigue in patients with prostate cancer; the s…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: 177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer [Phase 3]
A Phase 3 trial comparing 177Lu-PSMA-617 with androgen receptor-directed therapy for progressive metastatic castration-resistant prostate ca…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: A Study of Cognitive Health in Survivors of Prostate Cancer
A clinical study assessing cognitive health in survivors of prostate cancer; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
Completion of a real-world intensive monitoring study evaluating the use of olaparib in Chinese patients with ovarian or prostate cancer.
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating head-to-head diagnostic efficacy of 68Ga-PSMA-11 PET imaging versus mpMRI for diagnosing prostate c…